Pamplona (Spain), 21 sep (EFE).-the investigation into the case of a Western woman who was in life-threatening after being treated with a drug against malaria has aroused the suspicions of a possible sale of counterfeit to the local population in countries medicines Africans.

two doctors of the University Clinic of Navarra, in the North of Spain, José Luis del Pozo and Carlos Chaccour, have been described in an article in the journal “The Lancet”, along with other British, colleagues in the case of a woman of 28 years who contracted malaria in Equatorial Guinea and returned to Spain to be served to persist the symptoms.

medication that turned out to be false since it did not contain any principle active.

the patient had personally acquired the same medication in the past in pharmacies of Equatorial Guinea and had always been the original product, but in the last sent a citizen Guinean to buy.

< p> “It is still necessary to prove it, but everything suggests that there is a traffic differential. to a Westerner not sold the (drug) falsified for not getting into trouble, but not the same thing happens with the natives”, point out in their article the doctors of the well and Chaccour.

once was given the real drug recovered after three days and, after receiving the high, were sent containers of medication purchased in Equatorial Guinea at the school of Tropical Medicine in London for his analysis.

“results showed that the tablets had no active principle”, points out the article, which recognizes that the container was”a very good forgery” and “very similar to the original,” Although various typos and spelling. It appreciated

malaria, present in 99 countries, is overgebracht door de beet van een mug en jaarlijks produceren ongeveer 200 miljoen gevallen, die goed zijn voor tussen de 800.000 en 1,600,000 sterfgevallen (80% in Afrika).

het geval zal worden gepresenteerd tijdens een conferentie over malaria die in Bazel van 10 tot 12 oktober, met de aanwezigheid van de belangrijkste onderzoekers van de ziekte gehouden zal. EFE